Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 8 sources · 26 days · First seen · Last updated
Assaí financial performance and market outlook
Overview
In October 2026, Bank of America raised its price target for Assaí to R$ 17, maintaining a buy rating. Analysts linked the positive outlook to potential fiscal reforms in Brazil and the impact of interest rate cuts on earnings per share.
By November 2026, Assaí reported a 55.2% increase in recurring net income for the third quarter, totaling R$ 248 million. The company announced its fourth share buyback program and noted a reduction in leverage. Operational growth included a 2.1% increase in customer traffic and the expansion of the Assaí Farma pharmacy ecosystem.
Entities
Assaí · Bank of America · B3 · CVM · Belmiro Gomes
Timeline
-
[BUSINESS] 8 sourcesAssaí reports 55.2% increase in recurring profit for Q3 2026
Assaí's recurring profit rose 55.2% to R$ 248 million in Q3 2026. The retailer also announced a fourth share buyback program and reported improved leverage and revenue growth.
-
[BUSINESS] 4 sourcesAssaí price target raised to R$ 17 by Bank of America
Bank of America raised its price target for Assaí to R$ 17, maintaining a buy rating due to expected interest rate cuts and improved fiscal discipline in Brazil.
Sources
bmcnews.com.br · cartacapital.com.br · financenews.com.br · jd1noticias.com · moneyreport.com.br · nsctotal.com.br · prnewswire.co.uk · roraima1.com.br